- Home
- SVII vs COYA Comparison
SVII vs COYA Comparison
Compare SVII & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- COYA
- Stock Information
- Founded
- SVII 2021
- COYA 2020
- Country
- SVII United States
- COYA United States
- Employees
- SVII N/A
- COYA N/A
- Industry
- SVII Blank Checks
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- SVII Finance
- COYA Health Care
- Exchange
- SVII Nasdaq
- COYA Nasdaq
- Market Cap
- SVII 119.4M
- COYA 107.0M
- IPO Year
- SVII 2022
- COYA 2022
- Fundamental
- Price
- SVII $13.40
- COYA $6.48
- Analyst Decision
- SVII
- COYA Strong Buy
- Analyst Count
- SVII 0
- COYA 5
- Target Price
- SVII N/A
- COYA $16.20
- AVG Volume (30 Days)
- SVII 144.6K
- COYA 132.7K
- Earning Date
- SVII 01-01-0001
- COYA 11-05-2025
- Dividend Yield
- SVII N/A
- COYA N/A
- EPS Growth
- SVII N/A
- COYA N/A
- EPS
- SVII 0.17
- COYA N/A
- Revenue
- SVII N/A
- COYA $423,452.00
- Revenue This Year
- SVII N/A
- COYA $40.80
- Revenue Next Year
- SVII N/A
- COYA N/A
- P/E Ratio
- SVII $83.50
- COYA N/A
- Revenue Growth
- SVII N/A
- COYA N/A
- 52 Week Low
- SVII $11.20
- COYA $4.65
- 52 Week High
- SVII $14.80
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- SVII 61.65
- COYA 51.60
- Support Level
- SVII $12.18
- COYA $6.06
- Resistance Level
- SVII $14.80
- COYA $7.75
- Average True Range (ATR)
- SVII 0.50
- COYA 0.45
- MACD
- SVII 0.14
- COYA 0.04
- Stochastic Oscillator
- SVII 53.30
- COYA 28.05
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.